Mandarin at Lutetia and Conservatorium: brand reset or profitability test
The main article framed the Mandarin transition as one of Elrov's core 2026 proof points. This follow-up shows that 2025 already changed occupancy, distribution, and positioning, but still did not prove that the new brand can lift pricing and profit at the two flagship hotels.
Why come back specifically to Lutetia and Conservatorium
The main article marked the Mandarin Oriental transition as one of Elrov's central proof tests for 2026. This follow-up does not reopen the whole hotel story. It isolates only the two assets that now define that test, Lutetia in Paris and Conservatorium in Amsterdam, and asks a narrower question: has Mandarin already changed the economics of the hotels, or has it mainly changed the brand, distribution, and the market's expectations.
There is already a real shift. The agreements were signed in December 2024, Mandarin began providing management and operating services in April 2025, and both hotels moved into the Mandarin loyalty program. The company also says that from the start of 2026 sales, marketing, and distribution in Paris and Amsterdam are meant to be handled exclusively by Mandarin. In other words, 2025 was a real transition year. Precisely for that reason, it also shows what still has not been proved.
What Mandarin has already changed, and what still is not proof
At first glance there is one clear commercial positive. Occupancy improved at both hotels. Lutetia rose to 48.8% from 42.3%, and Conservatorium rose to 60.2% from 54.9%.
But occupancy is only half the story. Average room rates fell at both hotels. At Lutetia, ADR fell to about EUR 1,233 from about EUR 1,258. At Conservatorium, it fell to about EUR 709 from EUR 732. At Lutetia, the weaker rate was offset by better occupancy, so RevPAR still rose to ILS 2,344 from ILS 2,134. At Conservatorium, even that did not happen, and RevPAR fell to ILS 1,557 from ILS 1,609.
| Hotel | Occupancy 2024 | Occupancy 2025 | ADR 2024 | ADR 2025 | RevPAR 2024 | RevPAR 2025 | Read |
|---|---|---|---|---|---|---|---|
| Lutetia | 42.3% | 48.8% | about EUR 1,258 | about EUR 1,233 | ILS 2,134 | ILS 2,344 | better occupancy, weaker rate, only partial commercial improvement |
| Conservatorium | 54.9% | 60.2% | about EUR 732 | about EUR 709 | ILS 1,609 | ILS 1,557 | better occupancy, but weaker rate and weaker revenue per available room |
The bigger problem is that the occupancy improvement did not translate into profit. In the company's hotel operating-surplus table, Lutetia fell to ILS 22 million in 2025 from ILS 48 million in 2024, while Conservatorium moved to a negative ILS 5 million from a positive ILS 4 million.
That is the key point of this whole follow-up. Mandarin has already changed the sales and distribution layer, but it has not yet proved the hotel economics. Lutetia already shows some commercial resilience because RevPAR rose despite a weaker ADR. Conservatorium does not even show that. In both cases, 2025 still failed to generate earnings that prove the new brand is already working economically.
The company almost says this directly in Lutetia's case. It writes that as of the report date, Lutetia had still not reached representative operating profit. The Mandarin move does not cancel that sentence. It simply shifts the test into the next year.
The management contract: strong brand, but also a clear cost layer
To understand why 2025 is not enough, it helps to look at the contract economics. Mandarin is entitled to a base management fee of 2% of gross revenue in year one, 2.5% in year two, and 3% from year three onward. In addition, it gets 2.5% of gross revenue for sales, marketing, and advertising, plus an incentive fee equal to 10% of adjusted gross operating profits.
In contract terms, even before the incentive fee, Mandarin takes 4.5% of gross revenue in year one, 5% in year two, and 5.5% from year three onward. The company is also explicit that this compensation does not include expense reimbursement or the funding that the hotel companies still need to provide for hotel operations. So for the move to work economically, Mandarin does not just need to bring in more bookings. It needs to bring in better bookings, at better rates, with enough earnings quality to carry a structurally heavier fee layer.
That is especially relevant at Conservatorium. The agreement also includes advisory services for the planning of a hotel refresh and upgrade so that the rooms and public areas fit the Mandarin brand. That may be the right investment. In the short term, however, it also reinforces the sense that 2025 was still a brand-transition year, not a proof year.
Lutetia: the valuation already gives Mandarin credit, but not a free pass
The place where the gap between brand and proof is sharpest is Lutetia. The attached valuation puts the hotel at EUR 480 million. The valuer explicitly says the property's value is strengthened by the Mandarin brand and operator, and by the terms of the management agreement, which add an extra layer of income security.
But the same valuation contains the more important caveat. The valuer says it did not receive long-term trading projections from Mandarin and therefore had to work on a restricted-information basis, using its own assumptions. More importantly, it states directly that the capitalisation and discount-rate profile includes a risk premium for performance levels that have not yet been demonstrated under Mandarin.
That is probably the single most important line in this continuation. Lutetia's value already gives Mandarin credit, but it does not treat Mandarin as fully proved. It treats it as a positive strategic move whose upside is real, while still keeping a discount for uncertainty.
The 2025 numbers support that same reading. In Lutetia's valuation table, actual EBITDAR fell to EUR 5.589 million from EUR 11.805 million in 2024, despite higher occupancy. So even in the flagship asset, where the brand should theoretically have the clearest commercial effect, the first year under Mandarin still did not prove that the commercial reset is fully flowing through into earnings.
What really has to happen in 2026
Elrov is not setting a soft target here. It says that if the operating targets are met, 2026 should generate for the company not less than EUR 20 million of operating surplus from Lutetia and Conservatorium together. That is no longer a polishing target. It is a step-change target.
| 2026 checkpoint | Why it matters |
|---|---|
| The ADR decline has to stop at both hotels | Without room-rate recovery, Mandarin remains an occupancy engine rather than a return engine |
| Conservatorium has to move back into positive operating surplus | Otherwise the brand refresh will still look like an expensive transition rather than a value-creating move |
| Lutetia has to show profit that starts to support the EUR 480 million valuation | Otherwise the valuation will keep leaning on forward assumptions rather than demonstrated performance |
| 2026 is the first full year of exclusive Mandarin sales and distribution | Only then can the full model be judged instead of a nine-month transition version |
That is exactly why this continuation matters. 2025 did not prove that Mandarin was a mistake. But it also did not prove that the move is already working in earnings. For now, Mandarin has improved the odds, not the proof. The proof has to appear in 2026, through room rates, through operating surplus, and through whether Lutetia and Conservatorium can turn back into profitable flagship hotels rather than only prestigious flagship assets.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.